{"name":"GC Cell Corporation","slug":"gc-cell-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Activated T lymphocyte","genericName":"Activated T lymphocyte","slug":"activated-t-lymphocyte","indication":"Treatment of various cancers","status":"phase_2"},{"name":"Immuncell-LC","genericName":"Immuncell-LC","slug":"immuncell-lc","indication":"Advanced gastric cancer","status":"phase_3"}]}],"pipeline":[{"name":"Activated T lymphocyte","genericName":"Activated T lymphocyte","slug":"activated-t-lymphocyte","phase":"phase_2","mechanism":"Activated T lymphocytes are a type of immune cell that play a key role in the body's defense against infection and disease.","indications":["Treatment of various cancers"],"catalyst":""},{"name":"Immuncell-LC","genericName":"Immuncell-LC","slug":"immuncell-lc","phase":"phase_3","mechanism":"Immuncell-LC is an autologous cell therapy that activates and expands a patient's own immune cells to enhance anti-tumor immunity.","indications":["Advanced gastric cancer","Colorectal cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4zS1JrcjJtT25HWVRSNE1EdkIxNzVKWHJubnltNXl3LWYzSHoxQW16Sy1wUGlYQk5wOTQzRzk5RmVkMGJna2RVMENrcXdJbklkUlE2TUhQN3FxR2dmTHBBNElmNW01X3FUbTV4eHlB0gFyQVVfeXFMTWh5bGpxTUkzOENEWU1vb2hENDhSU2N3OWNKdzlBRDB4QXVxcUItaHJnQU80NWJocHBFZ1VsWVJpSjFxZzB5RU9iRDVuLUtpNFFxOG5GZWxvblJiT012bkpUcm1TTzNaLWpkUkxtMUdtaXZn?oc=5","date":"2026-02-27","type":"regulatory","source":"koreabiomed.com","summary":"GC Cell seeks approval for China-licensed multiple myeloma CAR-T therapy Fucaso - koreabiomed.com","headline":"GC Cell seeks approval for China-licensed multiple myeloma CAR-T therapy Fucaso","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBEVzNEamFtcUZESVJucGFtRHQzN0tIc2RFcnlzMFFtRzF2ekpUdVRPLVR6cHoyNzZ6RzVJMGxYQ004b1NQTTFvVWZGYzM5Z0huel9SNUM4UjFSeXNIazZBeHpqeTlHdDJBU0RDLVBB0gFyQVVfeXFMT1FUZGo5QUVmcXM1Y0R5cVVDeW42eDgzVDF0UWNvejRwZGJSZE5MT2tZTVRtOEtHSHQ1djhiZFhKdEk5QkVXX0s5LWxON0dJRzNla0U0YlZIXzBGTl9YTkJKbmd6TWpvbm1EcS14RFhhbzVR?oc=5","date":"2026-01-27","type":"earnings","source":"koreabiomed.com","summary":"GC Biopharma swings to profit in Q4, boosts 2025 sales 18.5% - koreabiomed.com","headline":"GC Biopharma swings to profit in Q4, boosts 2025 sales 18.5%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOV24xc0JpeF9iX1ZNaGlPVlVrbEE2eE1uRkV1MjJUTUhkRmdDTmNZUlJJMENXazczSVJaQkdIcjdrSFhNU3NrendDTGpCb1dLSzViNnR1Y0dTbUZxUkFCMFJPLTJZZWlSd2dzSHZCU2t5Z0o2aXJWaEhqTmR1QjI5ZGZfMWFUYUpTcXAwZDUyaDlSNDViMjgtSGdpY3VWWDhDQzlJVGZVbG1ZNGM5Ull1Z0w1dmh6QllKeFRzbG56R2UyVzluU01QaENPbjN4OExFc1I0bVpsOA?oc=5","date":"2026-01-09","type":"pipeline","source":"businesswire.com","summary":"GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update - businesswire.com","headline":"GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPdGJaTjFtZURoZUtuV0JvZXpZcGo1LXRhRHRwZUIxWDhmWTRnZzM5ci12b2N0TVlLWUtvWlJvNVdHa3Q0NDRiZVFaVlFBUDVIYXdhRTFhaTF2dDBZR2MtaDZRU29UTDliNGNoOXBUSkJsa2F1T0tfYjgwTTZRc2paVNIBlAFBVV95cUxQdHZvWVFTOVNGbTFWNDluMDFrU0YtQWduYUx3U0lJaTNKaWRlMDA1QlRRTTRpWTZKQ3p1VndsY2M2MFBUcGNGZmQ5SzhjYU9EYmRqWUp6Yk9taHV3ajVDYVIzSEFqUHMxT3Faak8tLTh1cFdSTHhYQ1JHOWNEeXNOMlkxcHNXaXVfaUJ0ems4YmdJcE1q?oc=5","date":"2025-07-02","type":"pipeline","source":"Chosunbiz","summary":"Korea's pharmaceutical exports surge 28% as companies expand global presence - CHOSUNBIZ - Chosunbiz","headline":"Korea's pharmaceutical exports surge 28% as companies expand global presence - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1Jc01OUmd4RzlrVUVoZTQ5Y2xtWWxqR21yYkRfNGs4N3AxSU5weEF6ZjB2cnl2eVJNLXVlOWN3bTF0b1l0Zm1fUmcwY2N0bXRiWC1QYnVfdUMxTzZwdDd3NlUzRzFDcDRYZnRwbk9n0gFyQVVfeXFMTTdDVXdfWWdUS21oajRUQUhpX3F3bWZKWHNZbkhkcml3OXFHYmd0R0dMMVhwc3VKWXFRQ213dlVjMG0tQzV0Wl9CQU94Vl9hV2NLZHdUOUhudk1KM181OHcwZTlHVnVwek5ZQzd4ZnJaT3Zn?oc=5","date":"2025-06-27","type":"pipeline","source":"koreabiomed.com","summary":"GC Cell accelerates global expansion of ImmunCell-LC through tech transfer and media export to Indonesia - koreabiomed.com","headline":"GC Cell accelerates global expansion of ImmunCell-LC through tech transfer and media export to Indonesia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVlo0UlJ3YmZfN1Foa3J1end3NHMyb0hXekVqQ0h3X2l6SVFwcnZlQkdGNXhqZzFGZWMwTUxxZkU5QTBZcUNGNDRheUIxWWVkMkZySm9qMXU0bnVadmVaMGRHdEF6RjU3SDJWM0VqNWQyaUJlUkNWY3puLUNIb1pSbk1HZEtBZFNkdmlkN1EzTmM4bjFkNkFpRHc0NjlZRnpWMDE1VGhkUzg?oc=5","date":"2025-06-17","type":"deal","source":"BioWorld News","summary":"Korea biotech roundup: four financings, six R&D deals mid-June - BioWorld News","headline":"Korea biotech roundup: four financings, six R&D deals mid-June","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNZGtWZHFNbTBHS1YyTU1ENWd4Y09VQ3ZPbWQ2NmZyUHlVbl8zdU5JR1hwbl9aN2xQdlNHaWNSdWV4cjlOdEhHMGVSeEtkaWlVOFN5dGRZZHRHLUN4b1dBUmFGNGVIcWhTTi1NTnNnb00yUDlkLXRzTWVtTFZyT1ozbUtGTmxlUnZzZmEwQkZXSEVIXzR1VkxDWlluLVRXR0tDdTZteTQ0V2ZFbGM3TmJjVWM1TEI4MUlHWnRCOEwydmx6YUtreVMybWJoUWxkSkZtb3dYb1VJNjVLSTdFNWotdGY1ZnlxdnNRWkt1Q2VCeGVvbVpfUWptOXlISkhNZ01FQWF3Zks5YWVJQ0FVYkVpV2x1TnVTdVpK?oc=5","date":"2025-06-09","type":"regulatory","source":"prnewswire.com","summary":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight - prnewswire.com","headline":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxOR1EzZnBYSHc2SDJoZVVHcDdDcFZBNlY5b0tjMmhzNGd0SVdtclZuN0g5S1ZwZzVhODJUVnI1aXk2QTgxNTdJWVIwYzFRRVRwY2R2S1lZOHhhT04yNmx1X1R0d3BBZzFiRmJ0QVd1WTlabHpMcnlUYnlXanA4MG9ZTG84MURBRHBIS3IyVVVtb3pOT2ZFdlBwQXJjLWNweEkwTFhPaXI5Q1hZWFR2NWpWT2JQYkdpNDllS0dDejlsV0xaWGt5eEZIRTZGX1lrR3Q4RnFLMm11cnpocHJ3YUtaTkdfSDBPY0YwdGJWaUZ6Ylp6YjdkMUFDbFduSl9aVXRkeG9GSTQ5MDhzcGlsSThxdzI1VUpZaFJWeUkycnI5NVZPRkhiNUxTN1hTajExTXpQRjJSM0F3?oc=5","date":"2024-07-21","type":"pipeline","source":"prnewswire.com","summary":"GC Cell and Lukas Announce Strategic Cooperation Agreement to Jointly Tap into the Innovative Cell Therapy including and beyond Korean and Taiwanese Market - prnewswire.com","headline":"GC Cell and Lukas Announce Strategic Cooperation Agreement to Jointly Tap into the Innovative Cell Therapy including and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPc3dVVDZOTGZ6Q0lTV1FodjRKUmtJNGxKbTZyb1ZBZjRrUERCZ1hDVzUydHA5N1J5ak1maVcwS0ZQTVR3Umtza09TOGtTWUxQV0lyYmxNUkxvUjh3X3VDVV9JX0l1Wk02WE9VTldtUHprRW5fWDZyajNUYVlORG4yV1ZSOGJ5c3VqaUc4Zm11OTVuaW03UmxLcC1KMV9IS3F4M0ZqT0Z5N3VHN3ZVeVVkd0VicFhPLUFBZG5BLUFBeExrSkNqa19SSERTWURDUmdL?oc=5","date":"2024-02-26","type":"pipeline","source":"BioSpace","summary":"GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj. - BioSpace","headline":"GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUDVKUjNta3h3R2k3eWFnSFlrOWMyNmE3UWJtajBobVBOVGpLSnFSeWNnMFdHaFlFNTQ1a2U5ejNGZW1uWGg4bWoySlY1X3lFd1Njd1dJV2QzWDYwN19GbXdTd0hnU0dUUDdSS2xjLUowXzZ1SWhacFV3SEQ2QVUybkxPNDJkZUhlSk01Zy1QZTg2a0RmUHZZLUVsQVJNLVZXT1pKQm1ZYjRVM05TN1dOVGxwMi1pOE1RbjBjbkhmejJLOTFUQ1lJemYxWXoyZWd5X1FaRTlsdm5OTTFnVy1Z?oc=5","date":"2022-04-19","type":"deal","source":"businesswire.com","summary":"GC Signs Definitive Agreement to Acquire US CDMO BioCentriq, Enhancing Global Capabilities - businesswire.com","headline":"GC Signs Definitive Agreement to Acquire US CDMO BioCentriq, Enhancing Global Capabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9oSGZJaUdNTms4d0Z2TmFMejFNODRBV0pubzV2MUVfREk5TXpNaFd4Q0ZNYjFxdUF1bVIwaktlYjJCR0lVTmNMSDNvbEdoQjIyRU5tOWdVOFkzdWc4Q0JJ?oc=5","date":"2021-07-18","type":"pipeline","source":"KED Global","summary":"Green Cross' two Kosdaq-listed cell therapy arms to merge - KED Global","headline":"Green Cross' two Kosdaq-listed cell therapy arms to merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5NSmdGR3FjZVY2VjNnVTNiQlJvNGxuVzBrOERQOXN6Tk43NmJkSzl1c04tcThxQ0c3YmVRSU81MVl1enduclRFSnlVcUJsWldad0k1WXdub3NHcVBsNWM0c05VRzNkLXg5bHFfVURFazk?oc=5","date":"2021-01-29","type":"deal","source":"KED Global","summary":"GC Lab Cell, Artiva ink $1.9 bn deal with MSD - KED Global","headline":"GC Lab Cell, Artiva ink $1.9 bn deal with MSD","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}